Filing Details
- Accession Number:
- 0001179929-24-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-14 16:38:00
- Reporting Period:
- 2024-02-12
- Accepted Time:
- 2024-02-14 16:38:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1179929 | Molina Healthcare Inc. | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690677 | Lowell Mark Keim | 2180 Harvard Street Suite 400 Sacramento CA 95815 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-12 | 1,264 | $388.61 | 50,267 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 4,251 | $387.94 | 46,016 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 4,351 | $387.00 | 41,665 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 1,203 | $385.80 | 40,462 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 1,815 | $384.58 | 38,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-12 | 2,116 | $383.82 | 36,531 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020.
Billionaire Hedge Funds
